William S. Korinek
Director Ejecutivo en Astrocyte Pharmaceuticals, Inc. .
Perfil
William S.
Korinek is the founder and CEO of Astrocyte Pharmaceuticals, Inc. which was founded in 2014.
He is currently a partner at Dreavent, Inc. where he holds the title of Partner.
Dr. Korinek was a Vice President at Pfizer Inc. from 2009 to 2014.
He received his doctorate degree from Harvard University in 2000 and his undergraduate degree from Concordia College (Minnesota) in 1995.
Cargos activos de William S. Korinek
| Empresas | Cargo | Inicio |
|---|---|---|
Astrocyte Pharmaceuticals, Inc.
 Astrocyte Pharmaceuticals, Inc. BiotechnologyHealth Technology Astrocyte Pharmaceuticals, Inc. operates as a drug development company. The firm focuses on neuroprotective strategy to protect and repair neurons that are damaged by selectively stimulating astrocytes. The company was founded by William S. Korinek and James D. Lechleiter in 2014 and is headquartered in Cambridge, MA. | Director Ejecutivo | 01/08/2014 |
Dreavent, Inc.
 Dreavent, Inc. Investment ManagersFinance Dreavent, Inc (Dreavent) is a venture capital firm founded in 2020 by Gorka Fius and Leo Walter. The firm is headquartered in Cambridge, Massachusetts. | Inversor de Capital Privado | - |
Antiguos cargos conocidos de William S. Korinek.
| Empresas | Cargo | Fin |
|---|---|---|
| PFIZER, INC. | Inversor de Capital Privado | 01/07/2014 |
Formación de William S. Korinek.
| Harvard University | Doctorate Degree |
| Concordia College (Minnesota) | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Astrocyte Pharmaceuticals, Inc.
Astrocyte Pharmaceuticals, Inc. BiotechnologyHealth Technology Astrocyte Pharmaceuticals, Inc. operates as a drug development company. The firm focuses on neuroprotective strategy to protect and repair neurons that are damaged by selectively stimulating astrocytes. The company was founded by William S. Korinek and James D. Lechleiter in 2014 and is headquartered in Cambridge, MA. | Health Technology |
Dreavent, Inc.
Dreavent, Inc. Investment ManagersFinance Dreavent, Inc (Dreavent) is a venture capital firm founded in 2020 by Gorka Fius and Leo Walter. The firm is headquartered in Cambridge, Massachusetts. | Finance |
- Bolsa de valores
- Insiders
- William S. Korinek